Deutsch; Annual Report 2019 » With Group net income of EUR 1.28 billion Hannover Re achieved another record result. Our consolidated financial statements responsive to Item 18 of this Annual Report on Form 20-F (Annual Report) are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). Download the Annual Report 2019 (PDF 3.8 MB), Visit the 2019 Annual Reporting Suite section. The financial stake in Ströer SE & Co. KGaA was transferred to Deutsche Telekom Trust e.V. Our Annual Report 2019 provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results. This site is intended for a global audience. € für den Cash Capex (vor Investitionen in Spektrum) angepasst (Konzern-Zwischenbericht zum 30. Constant currencies (cc), core results and free cash flow are non-IFRS measures. Germany (Deutschland) Deutsch; India English; Italy (Italia) Italiano; Spain (España) Español; United Kingdom English; United States English; Site Search. Novartis bleibt auf Wachstumskurs: Nach einem starken dritten Quartal, hebt der Basler Pharmakonzern den Ausblick für das Gesamtjahr an. EEX Group Geschäftsbericht 2019 3 Global Report Gesellschaftliche Verantwortung Management Gastbeitrag Konzernlagebericht Konzernabschluss Report Success Report 2019 2018 Veränderung in % Gewinn- und Verlust-Rechnung Umsatzerlöse T€ 304.212 267.654 +14 Ergebnis vor Zinsen, Steuern und Abschreibungen (EBITDA) T€ 121.116 111.612 +9 Unless otherwise noted, all growth rates in this Release refer to same period in prior year. Hannover Re Group. This site is intended for a global audience. COMPENSATION REPORT – EDITORIAL DR. BARBARA FREI-SPREITER 4 «Agile and flexible into the future» Agility and flexibility are two key virtues these days. Im Jahr 2019 profitierten 1. 2 GESCHÄFTSBERICHT 2012 DER NOVARTIS GRUPPE Konzernübersicht novartis bietet medizinische Lösungen an, um damit auf die sich verändernden bedürfnisse von … Geschäftsbericht 2019 Vorwort Sehr geehrte Damen und Herren, Ihr Jörg Wieczorek - Vorsitzender - die Corona-Pandemie hat Deutsch - land, Europa und die ganze Welt vor bislang nie dagewesene Herausfor - derungen gestellt. In 2019, we recorded excellent sales development of 31% and organic sales growth of 16%. Documents Novartis results in XML format in line with requirements of the US Securities and Exchange Commission (SEC). € million 2019 2018 2017 2016 2015 Auftragseingang 2453.8 2303.5 2265.3 2156.6 2261.2 Umsatz 2383.2 2245.9 2205.0 2165.7 2334.8 Auftragsbestand 1409.3 1353.9 1260.8 1200.6 Menschen bei KSB Der Erfolg von Unternehmen Hier finden Sie eine Übersicht aller Geschäftsergebnisse des letzten Kalenderjahres. Ergebnisse Q2 und Halbjahr 2020 Dienstag, 21. GESCHÄFTSBERICHT 2019 2 Mission: Unsere Kompetenz – damit Sie Heilmitteln vertrauen können. Novartis delivered strong performance in 2019. Informationen auf Deutsch. 3. Bilanzsumme 0,20% Gesamtaufwand für die Verwaltung des Vermögens Our Executive Team talks innovation highlights from the third quarter of 2019 $NVS. English (PDF 5 MB) Novartis in Society ESG Report 2019 Integrated Annual Report 2019 summary - German (pdf, 9.33 MB) Sustainability performance report 2019 (pdf, 5.01 MB) Integrated Profit and Loss Statement (IP&L) (pdf, 751.67 KB) GRI Content Index 2019 (pdf, 155.16 KB) Materiality Review 2019 (pdf, 1.25 MB) Glossary of non-GAAP measures. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.2. € auf rund 24,1 Mrd. € 2019 … Management‘s Review Annual Report 2019 We are very pleased with the progress we made in 2019. The Digital Annual Review 2019 highlights our progress against the company’s five strategic priorities on an interactive page. Pkm 1) 2019 A 32,7 2018 A A33,3 2017 A 33,3 2016 A 32,6 2015 A 34,7 w 2019 zu 2018: – 1,8 % Ergebnis nach Steuern 2) — in Mio. Download (PDF 3.83 MB) Related Items. Core businesses in pharmaceuticals, vaccines, consumer health, generics and animal health. Wir konnten Alcon auf den Wachstumspfad zurückfüh-ren und Dabei handelt es sich um eine Augenerkrankung, die Geschäftsbericht 2019 Wichtige Kennzahlen Aus der Bilanz in Mrd. These presentations remain on the Novartis website for historical purposes only. « Jean-Jacques Henchoz Chairman of the Executive Board Foreword. Prior-year comparatives were not adjusted. Bank Cler – Geschäftsbericht 2019 4 Bilanz 31.12.2019 31.12.2018 Bilanzsumme in 1000 CHF 18 815 719 17 900 140 • Veränderung in % 5,1 2,2 Kundenausleihungen in 1000 CHF 15 983 866 15 455 757 • … An explanation of non-IFRS measures can be found on page 53 of the Condensed Financial Report. Constant currencies (cc), core results and free cash flow are non-IFRS measures. Novartis in Society US Report 2019. 9M 2020; HY 2020; Q1 2020; FY 2019; Alle; Neun Monate 2020 Investor update. “Item 5. We successfully launched Children’s TYLENOL Dissolve Packs, a novel way to administer pain relief for children. Our Annual Report 2018 provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results. Contact Alcon Investor Relations +41 589 112 110 +1 817 615 2789 investor.relations@alcon.com. 2019 Quarterly Results. Alcon shareholders may receive a hard copy of Alcon’s 2019 Annual Report or its 2019 Annual Report on Form 20-F filed with the US Securities and Exchange Commission, each of which contains our complete audited financial statements, free of charge, upon request. A very strong order book secures future growth in the project business. An explanation of non-IFRS measures can be found on page 42 of the Condensed Financial Report. Novartis Biotechnology leadership camp organized by it is a unique step. GESCHÄFTSBERICHT 2019 VARTA AG KONZERNLAGEBERICHT Im Rahmen dieser Anpassung wurde einer der beiden Vorstandsverträge im November 2019 von einer ursprüng- lich auf fünf Jahre ausgelegten, langfristigen aktienbasierten Vergütung auf eine auf drei Jahre ausgelegte Wert- zuwachsvergütung angepasst. As a major listed real estate company, we are obliged, and … Novartis hat in Deutschland die Initiative „Migräne muss in alle Köpfe“ ins Leben gerufen. Juli 2020 Medienmitteilung (PDF 0.2 MB) Zwischenbericht für das zweite Quartal 2020 (PDF 0.8 Veröffentlicht am 22.10.2019 Watch the media webcast … Novartis 2019 Financial Results . 2. Weil sich der vorliegende Geschäftsbericht jedoch auf das Geschäftsjahr vom 1. Plan Optik AG: Geschäftsbericht 2019 veröffentlicht DGAP-News: Plan Optik AG / Schlagwort(e): Jahresergebnis Plan Optik AG: Geschäftsbericht 2019 veröffentlicht 30.04.2020 / 14:36 Für … a Abweichend von den im zusammengefassten Lagebericht 2018 (Geschäftsbericht 2018) veröffentlichten Prognosen haben wir die Erwartungswerte 2019 unterjährig von rund 23,9 Mrd. Setting the benchmark in helicopters Due to enter into service in 2020, the H160 sets the benchmark for helicopter design. The Group Development operating segment also included the 12 percent financial stake in BT until March 23, 2018, when it was transferred to Deutsche Telekom Trust e.V. Readers should not rely upon the information in these pages as current or accurate after their publication dates. Before joining Deutsche Bank, he worked at McKinsey & Company in London focusing on a broad range of projects for the financial services industry. Media Releases. Dezember 2019 bezieht, wird in diesem die We achieved top-line growth and leveraged our financial strength to make significant, bold investments in initiatives to drive long-term growth. 2019 was dominated by the climate crisis and worldwide protests about climate policy. The investments we made in the strategic evolution of the Group in 2019 puts SGS in a strong position as we enter the final year of our Mission 2020 and beyond. Form 20-F documents Novartis results in line with requirements of the US Securities and Exchange Commission (SEC). Novartis AG and its consolidated affiliates publish consolidated financial statements expressed in US dollars. Geschaeftsbericht 2019_Englisch 6 24.02.2020 15:15:38. Q4 … Deutsche Telekom – Das Geschäftsjahr 2019 Konzern-Bilanz – Aktiva in Mio. Novartis announces the company’s fourth quarter and 2019 full year financial results. Find Novartis annual results, including media releases, annual reports, webcasts and presentations, and year-to-date figures. An explanation of non-IFRS measures can be found on page 55 of the Condensed Financial Report. Eckert & Ziegler Geschäftsbericht 2019 5 Geht es einem Unternehmen gut, profitieren alle Interessen-gruppen. Refers to continuing operations as defined on page 45 of the Condensed Financial Report, excludes Alcon, includes the businesses of Innovative Medicines and Sandoz (including the US generic oral solids and dermatology portfolio), as well as the continuing corporate functions. Swiss Prime Site ended the 2019 financial year with very positive results. This media asset is free for editorial broadcast, print, online and radio use. Geschäftsbericht letzte 10 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 16.11.2020 — annual reports To request a hard copy of the Annual Report, fill out the order form. Webcasts Media. Quartalsberichte; Geschäftsberichte; Hauptversammlung 2020; Geschäftsbericht und Jahresabschluss 2016 pdf Geschäftsbericht und Jahresabschluss 2015 pdf Geschäftsbericht und Jahresabschluss 2014 pdf Konzernabschluss und ausgewählte Anhangsangaben 2014 pdf Geschäftsbericht und Jahresabschluss 2013 pdf Geschäftsbericht und Jahresabschluss … Letter from the CEO Niels B. Christiansen CEO, the LEGO Group We outpaced the toy industry and took steps Refers to continuing operations, defined on page 43 of the Condensed Financial Report. 1. Elmos Semiconductor SE Heinrich-Hertz-Straße 1 44227 Dortmund Phone: +49 (0) 231 / 75 49-0 Fax: +49 (0) 231 / 75 49-149 info[at]elmos.com Deutsche And Other Scandal-Plagued Banks Should Learn From Novartis, Tenneco, And Volkswagen Mayra Rodriguez Valladares Senior Contributor Opinions expressed by Forbes … Q3 2019 Media Release (PDF 0.1 MB) Q3 2019 Financial Report (PDF 0.8 MB) Q2 2019 Media Release (PDF 0.2 MB) Q2 2019 Financial Report (PDF 0.6 MB) Q1 2019 Media Release (PDF 0.5 MB) Q1 2019 Financial Report (PDF 0.5 MB) 2018 Quarterly Results. It is restricted for other purposes. This website intends to use cookies to improve the site and your experience. Annual Report and Accounts 2019 Welcome to the Annual Report and Accounts for the year ended December 31, 2019. The fact that we did this even though 2019 was another relatively costly year for the reinsurance industry merely underlines our profitability. € Angabe 31.12.2019 31.12.2018 AKTIVA KURZFRISTIGE VERMÖGENSWERTE Zahlungsmittel und Zahlungsmitteläquivalente Forderungen aus Lieferungen und Leistungen Vertragsvermögenswerte Ertragsteuerforderungen Sonstige finanzielle Vermögenswerte Vorräte Übrige Vermögenswerte Zur Veräußerung gehaltene … Geschäftsbericht 2019 Einfach durch den Geschäftsbericht Der Umwelt zuliebe ERZ spart mit diesem digitalen Dokument pro Ausgabe rund 1,4 t Papier ein. In 2019, we took another step closer to becoming carbon-neutral in our own operations by the end of 2020, with both our US and Dutch facilities now 100%-powered by renewable energy. : +49 251 4905-0 dzhyp.de DZ HYP Geschäftsbericht 2019 in Mio. You can explore the main chapters and sub-chapters using the navigation bar at … Neun Monate 2020 Präsentation mit Anhang. Geschäftsbericht 2019 English (PDF 3.8 MB) Novartis in der Schweiz 2020 Deutsch (PDF 2.9 MB) Français (PDF 2.9 MB) English (PDF 2.9 MB) Campus Unternehmensmagazin Novartis, Nr. How medicines are making an impact in the lives of patients. 2019: +84,5 % Allzeithoch: 127,60 € 229 Neue am Start 713 insgesamt auf dem Weg 9 Bechtle AG Geschäftsbericht 2019 Lesen Sie die wichtigsten Konzernpublikationen online oder bestellen Sie sich eine gedruckte Version bequem nach Hause. Willkommen auf den Seiten der Novartis Austria GmbH Anlässlich des Welttags des Sehens wollen wir auf die feuchte altersabhängige Makuladegeneration aufmerksam machen. Geschäftsbericht 2019 Entwicklungen im Geschäftsjahr 2019 Verkehrsleistung — in Mrd. GESCHÄFTSBERICHT 2019 DZ HYP AG Rosenstraße 2 20095 Hamburg Tel. Patienten von Produkten, Mitarbeiter vom Einkom - men, das Gemeinwesen von Steuern. Novartis assumes no responsibility to update the information to reflect subsequent developments. By resolution of the Supervisory Board of Deutsche Telekom AG of February 20, 2019, Srini Gopalan was reappointed as the Board of Management member responsible for Europe for the period from January 1, 2020 to December 31, 2024. Januar 2020 auf den Namen TX Group AG umfirmiert. € auf rund 12,9 Mrd. Unless otherwise noted, all growth rates in this Release refer to same period in prior year. in August 2019 as plan assets to cover Deutsche Telekom’s existing pension obligations. 2 | Novartis Geschäftsbericht 2017 Brief des Präsidenten des Verwaltungsrats Liebe Aktionärin, lieber Aktionär Novartis hat 2017 substanzielle Fortschritte gemacht. September 2019). For further information, please refer to the section “Initial application of standards, interpretations, and amendments in the financial year” in the notes to the consolidated financial statements. 2018 English (PDF 8.6 MB) Unless otherwise noted, all growth rates in this Release refer to same period in prior year. An explanation of non-IFRS measures can be found on page 50 of the Condensed Financial Report. The Novartis in Society ESG Report details progress and demonstrates the company’s commitment in global health and corporate responsibility. Annual report 2019 Deutsche Börse Group: review and outlook. Download Centre. The interactive version of the Digital Annual Review is available here. Refers to continuing operations, defined on page 41 of the Condensed Financial Report. Neun Monate 2020 Präsentation. Annual report 2019 [PDF] The 2019 Annual Report offers a detailed insight into the business performance of Deutsche Börse Group. View recent presentations and learn more about upcoming events, Investors International:Call +41 61 324 79 44, Investors North America:Call +1 862 778 5052, Novartis Share Registry:For information relating to the registration of your shares, including name or address changes, please contact us by e‑mail or telephone:Call +41 61 324 72 04. COMPENSATION REPORT – EDITORIAL DR. BARBARA FREI-SPREITER 3 Geschaeftsbericht 2019_Englisch 3 24.02.2020 15:16:27. mehr. Wo Geschäftsbericht 19; Finanzbericht 19; Roche in Kürze 19; Roche im Überblick 19 ; Quartalsergebnisse Archiv. LafargeHolcim Half-Year Report 2019. Highlights Geschäftsbericht 2019. Our Annual Report 2019 provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results. An explanation of non-IFRS measures can be found on page 58 of the Condensed Financial Report. Compare Novartis financial and non-financial key performance indicators This website intends to use cookies to improve the site and your experience. Novartis Institutes for BioMedical Research. Geschaeftsbericht 2019_Englisch 2 24.02.2020 15:16:24. Key Figures Comparison. Financial Publication . Der Aktienkurs stieg 2019 um insgesamt 84,5%, so viel wie noch nie vorher in einem Jahr. Building on decades of pioneering work, the H160 integrates 68 different patented technologies. Constant currencies (cc), core results and free cash flow are non-IFRS measures. Allzeithoch. The Annual Review explains who we are and what we do, and highlights our progress against the company Download the media release English (PDF 0.1 MB ) | Deutsch (PDF 0.1 MB) | Français (PDF 0.1 MB) Condensed financial report (PDF 0.7 MB) Financial Results 2019 highlights. Sto SE & Co. KGaA | Geschäftsbericht 2019 Erklärung des Titelbildes: Für das neue Papiermuseum in Düren ließ sich der Kölner Architekt Klaus Hollenbeck vom Werkstoff inspirieren – Faltung, Prägung und Wasserzeichen wurden Own capitalized costs amounted to EUR 2.4 billion in the reporting year (2018: EUR 2.4 billion, 2017: EUR  Form 20-F documents Novartis results in line with requirements of the US Securities and Exchange Commission (SEC). During 2019, Airbus presented its latest products and services at the Paris Airshow. See the full letter in our 2019 Integrated Report. Constant currencies (cc), core results and free cash flow are non-IFRS measures. 4. Group Management Report . The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2019. Januar bis 31. CEO Video Message. PUBLICA – Geschäftsbericht 2019 65 163 Versicherte 42 301 Rentenbeziehende 104,1% Deckungsgrad 86,1% Ökonomischer Deckungsgrad CHF 41,0 Mia. Unless otherwise noted, all growth rates in this Release refer to same period in prior year. It will also ensure our industry leadership position in the TIC industry, sustainably creating long-term value for employees, customers, shareholders and for society at large. Novartis SWOT Analysis Novartis Strengths Below are the Strengths in the SWOT Analysis of Novartis: 1.Has a global reach in over 140 countries. We know how urgent the situation is: That is why we initiated further decisive steps in the reporting year to strengthen our contribution to fighting climate change. New product launches together with a disciplined focus on costs and operational efficiency helped us increase sales, operating income and operating profit margin. as plan assets. : +49 40 3334-0 Sentmaringer Weg 1 48151 Münster Tel. 1. «Die Tamedia AG wurde per 1. RZ 190417_Geschaeftsbericht CH-Englisch-Pantone-Final_Geschäftsbericht 2015-2016 Deutsch 17.04.19 14:32 Seite 4 8 INTEGRATED REPORT – INTERVIEW WITH THE CEO Geschaeftsbericht 2019_Englisch 8 24.02.2020 15:14:38. Disclaimer: The information in the presentations on these pages was factually accurate on the date of publication. Geschaeftsbericht 2019_Englisch 7 24.02.2020 15:14:36. Markiert: Berkshire Hathaway Geschäftsbericht 2019 6 AktienAutor / Berkshire Hathaway Inc. / Blogartikel / Branche / Empfehlung / Kaufen / Nachkaufalarm / S&P500 / Update 26. 7 CORPORATE GOVERNANCE – CAPITAL STRUCTURE Disclosure notifications of major shareholders Information regarding major shareholders is based on the register of shareholders or the notifications received by Swiss Prime Site AG. Novartis Institutes for BioMedical Research. The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2019. Net revenue; 2,936.0 (in €m; adjusted) Net profit; 1,105.6 (in €m; adjusted) Dividend per share; 2.90 (in €; proposal to AGM) Employees; 6,775; with 105 nationalities; Annual report. Our Annual Report 2019 provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results. 2019 on establishing a clear plan and path to achieve benchmark profitability in 2020, and the segment is already well on its way—as we delivered 90 basis points of adjusted income before tax margin* improvement in 2019. Computershare. Usage Rights & Restrictions . Präsident des Verwaltungsrats Novartis erzielte im Jahr 2019 ein starkes Ergebnis. 31 July 2019 . Constant currencies (cc), core results and free cash flow are non-IFRS measures. The integration of post-acute care facilities in Germany has been successfully completed and further strengthens our service business. The IFRS 16 “Leases” accounting standard has been applied since January 1, 2019. Novartis erzielt 2019 ein starkes Umsatzwachstum, Margen- steigerungen und bahnbrechende Innovationen mit der Markt- einführung fünf neuer Wirkstoffe Der Nettoumsatz der fortzuführenden Geschäftsbereiche1steigt 2019 um 9% (kWk2, +6% USD): o Die Geschäftseinheit Pharmaceuticals wächst um 12% (kWk), getragen von Cosentyx 2. The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2019. Jan 29, 2020. Download the media presentation (PDF 1.2 MB), Download the investor presentation (PDF 3.6 MB). Both seg-ments performed in line with expectations. Documents Novartis results in XML format in line with requirements of the US Securities and Exchange Commission (SEC). By continuing to browse the site you are agreeing to accept our use of cookies. € für das bereinigte EBITDA AL und von rund 12,7 Mrd. Die Einführung neuer Produkte sowie die Konzentration auf Kostendis- ziplin und betriebliche Effizienz haben uns geholfen, den Umsatz, das operative Ergebnis und die operative Gewinnmarge zu steigern.